Patents by Inventor Ce YAN

Ce YAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11324827
    Abstract: Disclosed are a multifunctionalized polyethylene glycol derivative and a preparation method therefor. The derivative has an H-shaped structure as represented by formula (1) and comprises one linear core LPEG and four PEG branch chains, where n1, n2, n3, and n4 respectively are the degrees of polymerization of the branch chains, U1 and U2 are trivalent branching groups connecting the core LPEG to two of the PEG branch chains, F1 and F2 contain a functional group or a protected form R01 thereof and may or may not contain a branched group G, correspondingly, the number of R01 is one or more, F1 and F2 are either identical or different, any one linking group in the molecule or any linking group formed with an adjacent heteroatom group can either remain stable or be degraded, and any one PEG segment in the molecule is discretely polydispersed or monodispersed.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: May 10, 2022
    Assignee: Xiamen Sinopeg Biotech Co., Ltd.
    Inventors: Wengui Weng, Chao Liu, Ce Yan, Shaofeng Wu, Chun Zhou
  • Publication number: 20220008007
    Abstract: The microneedle array includes a substrate having a central opening formed therethrough, and a plurality of microneedles positioned about a perimeter defining the central opening. At least one of the microneedles has a recess formed therein adjacent a tip thereof, and this recess is at least partially filled with a layer of active material. A sensor for detecting chemical analytes, biological analytes or the like may be constructed by providing two such microneedle arrays, with one serving as the working electrode and one serving as a reference electrode. The working electrode and the reference electrode may both be connected to a signal analyzer for detecting electrochemical signals. The working electrode and the reference electrode may be separate from one another or may be stacked together.
    Type: Application
    Filed: July 12, 2021
    Publication date: January 13, 2022
    Applicant: ICREATE TECHNOLOGY (ZHUHAI) CO., LTD.
    Inventors: SZE KEE TAM, YUE YUE ZHAO, KA MING NG, KA YIP FUNG, YONG YU, CHEUK HEI HERRY MAK, CE YAN, LINGDA XU
  • Patent number: 10660969
    Abstract: Disclosed are an 8-arm polyethylene glycol (PEG) derivative (formula 1), manufacturing method and modified bio-related substance thereby, wherein a tetravalent group U and four trivalent groups Ec form a highly symmetric octavalent central structure CORE0 together, Lc connects the octavalent center to eight PEG arms having polydiversity or monodiversity and having n1-n8 as the degrees of polymerization thereof. The terminal of one PEG chain is connected to at least one functional group F (k?1), and said PEG chain and F can be directly connected (g=0) or connected with a divalent linking group L0 connected with a terminal branched group G (g=1) therebetween. The latter provides more reacting sites to combine more pharmaceutical molecules, thereby increasing the drug loading capacity.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: May 26, 2020
    Assignee: Xiamen Sinopeg Biotech Co., Ltd.
    Inventors: Wengui Weng, Chao Liu, Ce Yan, Huihuang Su, Chun Zhou
  • Publication number: 20190365910
    Abstract: Disclosed are an 8-arm polyethylene glycol (PEG) derivative (formula 1), manufacturing method and modified bio-related substance thereby, wherein a tetravalent group U and four trivalent groups Ec form a highly symmetric octavalent central structure CORE0 together, Lc connects the octavalent center to eight PEG arms having polydiversity or monodiversity and having n1-n8 as the degrees of polymerization thereof. The terminal of one PEG chain is connected to at least one functional group F (k?1), and said PEG chain and F can be directly connected (g=0) or connected with a divalent linking group L0 connected with a terminal branched group G (g=1) therebetween. The latter provides more reacting sites to combine more pharmaceutical molecules, thereby increasing the drug loading capacity.
    Type: Application
    Filed: July 31, 2019
    Publication date: December 5, 2019
    Applicant: Xiamen Sinopeg Biotech Co., Ltd.
    Inventors: Wengui Weng, Chao Liu, Ce Yan, Huihuang Su, Chun Zhou
  • Patent number: 10434182
    Abstract: Disclosed are an eight-arm polyethylene glycol (PEG) derivative (formula I), production method therefor and modified bio-related substance thereby. Wherein, one tetravalent group U together with four trivalent groups Ec form a highly symmetrical octavalent group CORE0; Lc connects the octavalent group to eight PEG chains having polydispersity or monodispersity and having n1 to n8 as the degree of polymerization thereof; the terminal of one PEG chain is connected to at least one functional group F (k?1); said PEG chain and F therebetween can be directly connected (g=0) or be indirectly connected via a linking group L0 to a terminal end-branching group G (g=1); the latter provides more reactive sites for binding more drug molecules and increases the drug loading.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: October 8, 2019
    Assignee: Xiamen Sinopeg Biotech Co., Ltd.
    Inventors: Wengui Weng, Chao Liu, Ce Yan, Huihuang Su, Chun Zhou
  • Publication number: 20180214561
    Abstract: Disclosed are an eight-arm polyethylene glycol (PEG) derivative (formula I), production method therefor and modified bio-related substance thereby. Wherein, one tetravalent group U together with four trivalent groups Ec form a highly symmetrical octavalent group CORE0; Lc connects the octavalent group to eight PEG chains having polydispersity or monodispersity and having n1 to n8 as the degree of polymerization thereof; the terminal of one PEG chain is connected to at least one functional group F (k?1); said PEG chain and F therebetween can be directly connected (g=0) or be indirectly connected via a linking group L0 to a terminal end-branching group G (g=1); the latter provides more reactive sites for binding more drug molecules and increases the drug loading.
    Type: Application
    Filed: June 8, 2016
    Publication date: August 2, 2018
    Applicant: XIAMEN SINOPEG BIOTECH CO., LTD.
    Inventors: Wengui WENG, Chao LIU, Ce YAN, Huihuang SU, Chun ZHOU
  • Publication number: 20170312363
    Abstract: Disclosed are a multifunctionalized polyethylene glycol derivative and a preparation method therefor. The derivative has an H-shaped structure as represented by formula (1) and comprises one linear core LPEG and four PEG branch chains, where n1, n2, n3, and n4 respectively are the degrees of polymerization of the branch chains, U1 and U2 are trivalent branching groups connecting the core LPEG to two of the PEG branch chains, F1 and F2 contain a functional group or a protected form R01 thereof and may or may not contain a branched group G, correspondingly, the number of R01 is one or more, F1 and F2 are either identical or different, any one linking group in the molecule or any linking group formed with an adjacent heteroatom group can either remain stable or be degraded, and any one PEG segment in the molecule is discretely polydispersed or monodispersed.
    Type: Application
    Filed: September 30, 2015
    Publication date: November 2, 2017
    Applicant: XIAMEN SINOPEG BIOTECH CO., LTD.
    Inventors: Wengui WENG, Chao LIU, Ce YAN, Shaofeng WU, Chun ZHOU